Gliadin stimulation of murine macrophage inflammatory gene expression and intestinal permeability are MyD88-dependent: Role of the innate immune response in celiac disease

Journal of Immunology

Volumn 176, Issue 4, 2006, Pages 2512-2521

  Thomas, Karen E ^a   Sapone, Anna ^a   Fasano, Alessio ^a   Vogel, Stefanie N ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; GLIADIN; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 12; MYELOID DIFFERENTIATION FACTOR 88; PROTEIN P40; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; CELIAC DISEASE; CELL INTERACTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE PREDISPOSITION; GENE EXPRESSION REGULATION; GENE TRANSLOCATION; INNATE IMMUNITY; INTESTINE EPITHELIUM; INTESTINE MUCOSA PERMEABILITY; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

EID: 32044441878     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.176.4.2512     Document Type: Article

References (60)

1. Trier, J. S. 1998. Diagnosis of celiac sprue. Gastroenterology 115: 211-216.
2. Schuppan, D. 2000. Current concepts of celiac disease pathogenesis. Gastroenterology 119: 234-242.
3. Sollid, L. M., and E. Thorsby. 1993. HLA susceptibility genes in celiac disease: genetic mapping and role in pathogenesis. Gastroenterology 105: 910-922.
4. Madara, J. L., and J. S. Trier. 1980. Structural abnormalities of jejunal epithelial cell membranes in celiac sprue. Lab. Invent. 43: 254-261.
5. Schulzke, J. D., C. J. Bentzel, I. Schulzke, E. O. Riecken, and M. Fromm. 1998. Epithelial tight junction structure in the jejunum of children with acute and treated celiac sprue. Pediatr. Res. 43: 435441.
6. Wang, W., S. Uzzau, S. E. Goldblum, and A. Fasano. 2000. Human zonulin, a potential modulator of intestinal tight junctions. J. Cell Sci. 113: 4435-4440.
7. Fasano, A., T. Not, W. Wang, S. Uzzau, I. Berti, A. Tommasini, and S. E. Goldblum. 2000. Zonulin, a newly discovered modulator of intestinal permeability, and its expression in coeliac disease. Lancet 358: 1518-1519.
8. Ventura, A., G. Magazzu, and L. Greco. 1999. Duration of exposure to gluten and risk for autoimmune disorders in celiac patients. Gastroenterology 117: 197-303.
9. Di Pierro, M., R. Lu, S. Uzzau, W. Wang, K. Margaretten, C. Pazzani, F. Maimone, and A. Fasano. 2001. Zonula occludens toxin structure-function analysis: identification of the fragment biologically active on tight junctions and of the zonulin receptor binding domain. J. Biol. Chem. 276: 19160-19165.
10. Adams, D., E. Fang, S. N. Vogel, and A. Fasano. 2004. Zonulin is structurally and functionally related to the mucosal mast cell-derived mast cell protease II. Gastroenterology 126: A520 (Abstr.).
11. Thakar, M. S. Vogel, J. Kao, and A. Fasano. The Vibrio cholerae-generated zonula occludens toxin (Zot) N-terminal cleavage site contains a protease-activated receptor activating peptide (PAR-AP) that retains biological activity on intestinal tight junctions. 2005. Gastreonterology 128: A541 (Abstr.).
12. Lu, R., W. Wang, S. Uzzau, R. Vigorito, H. R. Zielke, and A. Fasano. 2000. Affinity purification and partial characterization of the zonulin/zonula occludens toxin (Zot) receptor from human brain. J. Neurochem. 74: 320-326.
13. Clemente, M. G., S. N. Vogel, M. Hollenberg, S. De Virgilis, and A. Fasano. Involvement of the proteinase-activated receptor 2 (PAR-2) in the Zot/zonulin-mediated regulation of intestinal tight junctions. 2004. Gastroenterology 126: A519 (Abstr.).
14. Fasano, A., C. Fiorentini, G. Donelli, S. Uzzau, J. B. Kaper, K. Margaretten, X. Ding, S. Guandalini, L. Comstock, and S. E. Goldblum. 1995. Zonula occludens toxin (Zot) modulates tight junctions through protein kinase C-dependent actin reorganization, in vitro. J. Clin. Invest. 96: 710-720.
15. Mays, R. W., K. A. Beck, and W. J. Nelson. 1994. Organization and function of the cytoskeleton in polarized epithelial cell as component of the protein sorting machinery. Curr. Opin. Cell Biol. 6: 16-24.
16. Wittchen, E. S., J. Haskins, and B. R. Stevenson. 1999. Protein interactions at the tight junction: actin has multiple binding partners, and ZO-1 forms independent complexes with ZO-2 and ZO-3. J. Biol. Chem. 274: 35179-35185.
17. Clemente, M. G., S. De Virgiliis, J. S. Kang, R. Macatagney, M. P. Musu, M. R. Di Pierro, S. Drago, M. Congia, and A. Fasano. 2003. Early effects of gliadin on enterocyte intracellular signalling involved in intestinal barrier function. Gut 52: 218-223.
18. Drago S., R. El Asmar, M. Di Pierro, M. G. Clemente, A. Sapone, M. Thakar, G. Iacono, A. Carroccio, C. D'Agate, T. Not, et al. Gliadin, zonulin, and gut permeability: effect on celiac and nonceliac intestinal mucosa and intestinal cell lines. Scand. J. Gastroenterol. In press.
19. Sander, G. R., A. G. Cummins, T. Henshall, and B. C. Powell. 2005. Rapid disruption of intestinal barrier function by gliadin involves altered expression of apical junctional proteins. FEBS Lett. 579: 4851-4855.
20. McIntire, F. C., H. W. Sievert, G. H. Barlow, R. A. Finley, and A. Y. Lee. 1967. Chemical, physical, biological properties of a lipopolysaccharide from Escherichia coli K-235. Biochemistry 6: 2363-2372.
21. De Ritis, G., P. Occorsio, S. Auricchio, F. Gramenzi, G. Morisi, and V. Silano. 1979. Toxicity of wheat flour proteins and protein-derived peptides for in vitro developing intestine from rat fetus. Pediatr. Res. 13: 1255-1261.
22. Shan, L., O. Molberg, I. Parrot, F. Hausch, F. Filiz, G. M. Gray, L. M. Sollid, and C. Khosla. 2002. Structural basis for gluten intolerance in celiac sprue. Science 297: 2275-2279.
23. Maiuri, L., C. Ciacci, I. Ricciardelli, L. Vacca, V. Raia, S. Auricchio, J. Picard, M. Osman, S. Quarantine, and M. Londei. 2003. Association between innate response to gliadin and activation of pathogenic T cells in celiac disease. Lancet 362: 30-37.
24. Perera, P. Y., S. N. Vogel, G. R. Detore, A. Haziot, and S. M. Goyert. 1997. CD14-dependent and CD14-independent signaling pathways in murine macrophages from normal and CD14 knockout mice stimulated with lipopolysaccharide or taxol. J. Immunol 158: 4422-4429.
25. Kawai, T., O. Adachi, T. Ogawa, K. Takeda, and S. Akira. 1999. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 11: 115-122.
26. Adachi, O., T. Kawai, K. Takeda, M. Matsumoto, H. Tsutsui, M. Sakagami, K. Nakanishi, and S. Akira. 1998. Targeted disruption of the MyD88 gene results in loss of 1L-1- and IL-18-mediated function. Immunity 9: 143-150.
27. Salkowski, C. A., and S. N. Vogel. 1992. IFN-γ mediates increased glucocorticoid receptor expression in murine macrophages. J. Immunol. 148: 2770-2777.
28. El Asmar, R., P. Panigrahi, P. Bamford, I. Berti, T. Not, G. V. Coppa, C. Catassi, and A. Fasano. 2002. Host-dependent zonulin secretion causes the impairment of the small intestine barrier function after bacterial exposure. Gastroenterology 123: 1607-1615.
29. Manthey, C. L., P. Y. Perera, C. A. Salkowski, and S. N. Vogel. 1994. Taxol provides a second signal for murine macrophage tumoricidal activity. J. Immunol. 152: 825-831.
30. Barber, S. A., M. J. Fultz, C. A. Salkowski, and S. N. Vogel. 1995. Differential expression of interferon regulatory factor 1 (1RF-1), IRF-2, and interferon consensus sequence binding protein genes in lipopolysaccharide (LPS)-responsive and LPS-hyporesponsive macrophages. Infect. Immun. 63: 601-608.
31. Wynn, T. A., I. Eltoum, A. W. Cheever, F. A. Lewis, W. C. Cause, and A. Sher. 1993. Analysis of cytokine mRNA expression during primary granuloma formation induced by eggs of Schitosoma mansoni. J. Immunol. 151: 1430-1440.
32. Gazzinelli, R. T., I. Eltoum, T. A. Wynn, and A. Sher. 1993. Acute cerebral toxoplasmosis is induced by in vivo neutralization of TNF-α and correlates with the down-regulated expression of inducible nitric oxide synthase and other markers of macrophage activation. J. Immunol. 151: 3672-3681.
33. Sher, A., R. I. Coffman, S. Heiny, P. Scott, and A. W. Chever. 1990. Interleukin 5 is required for the blood and tissue eosinophilia but not granuloma formation induced by infection with Schistosoma mansoni. Proc. Natl. Acad. Sci. USA 87: 61-65.
34. Doherty, T. M., R. A. Seder, and A. Sher. 1996. Induction and regulation of IL-15 expression in murine macrophages. J. Immunol. 156: 735-741.
35. Svetie, A., F. D. Finkelman, Y. C. Jian, C. W. Dieffenbauch, D. E. Scott, K. F. McCarthy, A. D. Steinberg, and W. C. Cause. 1991. Cytokine gene expression after in vivo primary immunization with goat antibody to mouse IgD antibody. J. Immunol. 147: 2391-2397.
36. Salkowski, C. A., G. Detore, A. Franks, M. C. Falk, and S. N. Vogel. 1998. Pulmonary and hepatic gene expression following cecal ligation and puncture: monophosphoryl lipid A prophylaxis attenuates sepsis-induced cytokine and chemokine expression and neutrophil infiltration. Infect. Immun. 66: 3569-3578.
37. Medvedev, A. E., K. M. Kopydlowski, and S. N. Vogel. 2000. Inhibition of lipopolysaccharide-induced signal transduction in endotoxin-tolerized mouse macrophages: Dysregulation of cytokine, chemokine, and Toll-like receptor 2 and 4 gene expression. J. Immunol. 64: 5564.
38. -ΔγCT method. Methods 25: 402-408.
39. Medvedev, A. E., P. Henneke, A. Schromm, E. Lien, R. Ingalls, M. J. Fenton, D. T. Golenbock, and S. N. Vogel. 2001. Induction of tolerance to lipopolysaccharide and mycobacterial components of Chinese hamster ovary/CD14 cells is not affected by overexpression of Toll-like receptors 2 or 4. J. Immunol. 167: 2257-2267.
40. DeLude, R., A. Yoshimura, R. R. Ingalls, and D. T. Golenbock. 1998. Construction of a lipopolysaccharide reporter cell line and its use in identifying mutants defective in endotoxin, but not TNF-α, signal transduction. J. Immunol. 161: 3001-3009.
41. Lien, E., T. J. Sellati, A. Yoshimura, T. H. Flo, G. Rawadi, R. W. Finberg, J. D. Carroll, T. Espevik, R. R. Ingalls, J. D. Radolf, and D. T. Golenbock. 1999. Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products. J. Biol. Chem. 274: 33419-33425.
42. Heine, H., C. J. Kirschning, E. Lien, B. G. Monks, M. Rothe, and D. T. Golenbock. 1999. Cutting edge: cells that carry a null allele for Toll-like receptor 2 are capable of responding to endotoxin. J. Immunol. 162: 6971-6975.
43. Maiuri, M. C., D. De Stefano, G. Mele, B. Iovine, M. A. Bevilacqua, L. Greco, S. Auricchio, and R. Carnuccio. 2003. Gliadin increases iNOS gene expression in interferon-γ-stimulated RAW 264.7 cells through a mechanism involving NF-κB. Naunyn-Schmiedeberg's Arch. Pharmacol. 368: 63-71.
44. Jelinkova, L., L. Tuckova, J. Cinova, Z. Flegelova, and H. Tlaskalova-Hogenova H. 2004. Gliadin stimulates human monocytes to production of IL-8 and TNF-α through a mechanism involving NF-κB. FEBS Lett. 571: 81-85.
45. Tuckova, L., Z. Flegelova, H. Tlaskalova-Hogenova, and Z. Zidek. 2000. Activation of macrophages by food antigens: enhancing effect of gluten on nitric oxide and cytokine production. J. Leukocyte Biol. 67: 312-318.
46. Nikulina, M., C. Habich, S. B. Flohe, F. W. Scott, and H. Kolb. 2004. Wheat gluten causes dendritic cell maturation and chemokine secretion. J. Immunol. 173: 1925-1933.
47. Fasano, A., M. Sztein, R. Lu, and M. Tanner. 2004. Method to use Zot to inhibit lymphocyte proliferation in an antigen-specific manner. Patent No. U.S. 6,733,562 B1.
48. Vogel, S. N., K. A. Fitzgerald, and M. J. Fenton. 2003. TLRs: differential adapter utilization by Toll-like receptors mediates TLR-specific patterns of gene expression. Mol. Interv. 3: 466-477.
49. Poltorak, A., X. He, I. Smimova, M. Y. Liu, C. Van Huffel, X. Du, D. Birdwell, E. Alejos, M. Silva, C. Galanos, et al. Science 282: 2085-2088.
50. Qureshi, S. T., L. Lariviere, G. Leveque, S. Clermont, K. J. Moore, P. Gros, and D. Malo. 1999. Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4). J. Exp. Med. 189: 615-625.
51. Kim, C. Y., H. Quarsten, E. Berseng, C. Khosla, and L. M. Sollid. 2004. Structural basis for HLA-DQ2-mediated presentation of gluten epitopes in celiac disease. Proc. Natl. Acad. Sci. USA 101: 4175-4179.
52. Fasano, A. 2001. Pathological and therapeutical implications of macromolecules passage through the tight junction. In Tight Junctions. M. Cereijido and J. Anderson, eds. CRC Press, Boca Raton, FL. pp. 697-722.
53. Di Cagno, R., M. De Angelis, S. Auricchio, L. Greco, C. Clarke, M. De Vincenzi, C. Giovannini, M. D'Archivio, F. Landolfo, G. Parrilli, et al. 2004. Sourdough bread made from wheat and nontoxic flours and started with selected lactobacilli is tolerated in celiac sprue patients. Appl. Environ. Microbiol. 70: 1088-1096.
54. Counts, D. R., M. G. Clemente, and A. Fasano. 2002. The gut protein zonulin is increased in patients with type 1 diabetes and their first degree relatives. Pediatr. Res. 51: 123A (Abstr.).
55. Watts, T., I. Berti, A. Sapone, T. Gerarduzzi, T. Not, R. Zielke, and A. Fasano. 2005. Role of the intestinal tight junction modulator zonulin in the pathogenesis of type-1 diabetes in BB diabetic prone rats. Proc. Natl. Acad. Sci. USA 102: 2916-2921.
56. Meresse, B., Z. Chen, C. Ciszewski, M. Tretiakova, G. Bhagat, T. N. Krausz, D. H. Raulet, L. L. Lanier, V. Groh, T. Spies, et al. 2004. Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease. Immunity 21: 357-366.
57. Hue, S., J. J. Mention, R. C. Monteiro, S. Zhang, C. Cellier, J. Schmitz, V. Verkarre, N. Fodil, S. Bahram, N. Cerf-Bensussan, and S. Caillat-Zucman. 2004. A direct role for NKG2D/M1CA interaction in villous atrophy during celiac disease. Immunity 21: 367-377.
58. Abreu, M. T., M. Fukata, and M. Arditi. 2005. TLR signaling in the gut in health and disease. J. Immunol. 174: 4453-4460.
59. Rakoff-Nahoum, S., J. Paglino, F. Eslami-Varzaneh, S. Edberg and R. Medzhitov. 2004. Cell 118: 229-224.
60. Fukata, M., K. S. Michelsen, R. Eri, L. S. Thomas, B. Hu, K. Lukasek, C. C. Nast, J. Lechago, R. Xu, Y. Naiki, et al. 2005. Toll-like receptor-4 is required for intestinal response to epithelial injury and limiting bacterial translocation in a murine model of acute colitis. Am. J. Physiol. 288: G1055-G1065.